Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiretroviral therapy and peripheral T cell apoptosis in HIV
NL-OMON37267Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of efavirenz, nevirapine, atazanavir, lopinavir, darunavir and 3 more in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Peripheral T cell apoptosis. Started Jul 2012; status: active, not recruiting.
02
Drugs
efavirenznevirapineatazanavirlopinavirdarunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON37267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37267.